Home / Blog / Medication

Prozac vs. Zoloft: Half-Life, Approved Uses and Other Differences

Two pink cosmos flowers side by side, one in front of the other

Quick answer

Prozac (fluoxetine) and Zoloft (sertraline) are both SSRI antidepressants, and research hasn't named a clear winner between them. The biggest practical difference is how long they last: fluoxetine and its active breakdown product stay in the body for weeks, which affects missed doses, stopping and switching, while sertraline's half-life is about 26 hours. For adults, both are FDA-approved for depression, OCD and panic disorder; Zoloft is also approved for PTSD, social anxiety disorder and PMDD, and Prozac for bulimia nervosa. Both block the liver enzyme CYP2D6, and Prozac's label describes the stronger effect. The right choice depends on the person.

Key takeaways

  • Prozac and Zoloft are both SSRIs and share most of the same label warnings.
  • Fluoxetine stays in the body for weeks, which may soften a missed dose but means a longer wait before switching to some medications.
  • Zoloft has more approved uses on its own, but bulimia nervosa is on Prozac's label and not Zoloft's.
  • Any difference in how well they work looks small, so interactions, side effects and your own history usually guide the choice.

Prozac (fluoxetine) and Zoloft (sertraline) are two of the most familiar antidepressant names, and people often want to know which one is better. Research doesn’t name a clear winner. What sets them apart is mostly practical: how long each one stays in your body, what each is approved to treat, and how each affects other medications.

This post walks through those differences, starting from the FDA labels. Treat it as background for a conversation with your provider, not advice to choose one. Our Lexapro vs. Zoloft comparison covers much of the shared background; this one focuses on what makes Prozac different.

Two SSRIs on Different Timelines

Both are SSRIs, or selective serotonin reuptake inhibitors, and both are sold under their brand names and as generics. Prozac is the older of the two: its label lists its first U.S. approval in 1987, and Zoloft’s lists 1991. Their FDA labels (Prozac, Zoloft) share the core SSRI warnings:

  • The boxed warning about suicidal thoughts and behaviors in people up to age 24 (full wording in the comparison below).
  • Serotonin syndrome, a potentially serious reaction, and a higher risk of bleeding, especially alongside aspirin, anti-inflammatory pain relievers or blood thinners.
  • Setting off mania or hypomania in people with bipolar disorder, which is why both labels say to screen for it before starting.
  • Low sodium, a type of glaucoma, QT prolongation (a change in heart rhythm), caution in people with seizures, sexual side effects, and symptoms after stopping.

Neither can be taken with MAOIs (an older group of antidepressants) or with pimozide, an antipsychotic. Prozac’s label adds a second antipsychotic, thioridazine, to that list.

What Each Is FDA-Approved to Treat

The two lists overlap, but they aren’t the same. For adults:

  • Prozac (fluoxetine): major depressive disorder, OCD, panic disorder and bulimia nervosa, an eating disorder. Taken together with olanzapine, an antipsychotic, it’s also approved for depressive episodes of bipolar I disorder and for treatment-resistant depression (depression that hasn’t responded to two different antidepressants). Prozac on its own isn’t approved for either of those.
  • Zoloft (sertraline): major depressive disorder, OCD, panic disorder, PTSD, social anxiety disorder and premenstrual dysphoric disorder (PMDD).

So depression, OCD and panic disorder are on both lists. PTSD, social anxiety disorder and PMDD appear only on Zoloft’s label, while bulimia and the olanzapine combinations appear only on Prozac’s. Both are also approved for some uses in children and teens, and those uses differ; we see adults 18 to 65.

An FDA approval tells you which uses were formally studied and submitted, not the full range of what a medication may help. Providers sometimes prescribe an approved medication for another use when they judge it medically appropriate, which is called off-label use. Our depression guide lists the medications FDA-approved for depression and how they differ.

Is it this or that?

Prozac or Zoloft? The labels side by side

Prozac (fluoxetine)Zoloft (sertraline)
FDA-approved uses in adultsMajor depressive disorder, OCD, panic disorder and bulimia nervosa. With olanzapine: depressive episodes of bipolar I disorder and treatment-resistant depression.Major depressive disorder, OCD, panic disorder, PTSD, social anxiety disorder and PMDD.
How long it lastsHalf-life of 4 to 6 days with ongoing use; its active breakdown product, norfluoxetine, 4 to 16 days. Active medication stays in the body for weeks.Half-life of about 26 hours. Its main breakdown product is described as substantially less active.
Wait before starting an MAOIAt least 5 weeks after stopping.At least 14 days after stopping.
CYP2D6 (liver enzyme)A potent blocker; the effect may last 3 weeks or longer after stopping.A blocker, with a less prominent effect at lower doses than some others in its class.
Never combined withMAOIs, pimozide and thioridazine.MAOIs and pimozide. The oral solution contains alcohol and can't be used with disulfiram.
Breastfeeding (label)Reports of agitation, irritability, poor feeding and poor weight gain in some infants.Low levels in breast milk; no adverse reactions seen in a pooled analysis of 53 infants.
Shared warnings includeSerotonin syndrome, bleeding, mania or hypomania, caution with seizures, low sodium, angle-closure glaucoma, QT prolongation, sexual side effects, symptoms after stopping.The same list.
Label-specificBlood sugar effects in diabetes, a warning about effects on thinking and motor skills, and a section on its long half-life. QT: consider an ECG in people with risk factors.Can cause false-positive urine screening tests for benzodiazepines. QT: use with caution in people with risk factors.

Prozac (fluoxetine)

FDA-approved uses in adults
Major depressive disorder, OCD, panic disorder and bulimia nervosa. With olanzapine: depressive episodes of bipolar I disorder and treatment-resistant depression.
How long it lasts
Half-life of 4 to 6 days with ongoing use; its active breakdown product, norfluoxetine, 4 to 16 days. Active medication stays in the body for weeks.
Wait before starting an MAOI
At least 5 weeks after stopping.
CYP2D6 (liver enzyme)
A potent blocker; the effect may last 3 weeks or longer after stopping.
Never combined with
MAOIs, pimozide and thioridazine.
Breastfeeding (label)
Reports of agitation, irritability, poor feeding and poor weight gain in some infants.
Shared warnings include
Serotonin syndrome, bleeding, mania or hypomania, caution with seizures, low sodium, angle-closure glaucoma, QT prolongation, sexual side effects, symptoms after stopping.
Label-specific
Blood sugar effects in diabetes, a warning about effects on thinking and motor skills, and a section on its long half-life. QT: consider an ECG in people with risk factors.

Zoloft (sertraline)

FDA-approved uses in adults
Major depressive disorder, OCD, panic disorder, PTSD, social anxiety disorder and PMDD.
How long it lasts
Half-life of about 26 hours. Its main breakdown product is described as substantially less active.
Wait before starting an MAOI
At least 14 days after stopping.
CYP2D6 (liver enzyme)
A blocker, with a less prominent effect at lower doses than some others in its class.
Never combined with
MAOIs and pimozide. The oral solution contains alcohol and can't be used with disulfiram.
Breastfeeding (label)
Low levels in breast milk; no adverse reactions seen in a pooled analysis of 53 infants.
Shared warnings include
The same list.
Label-specific
Can cause false-positive urine screening tests for benzodiazepines. QT: use with caution in people with risk factors.

Both labels carry this warning. In short-term studies, antidepressants increased suicidal thoughts and behaviors in people up to age 24. Anyone taking one should be watched closely for worsening, especially during the first few months and at times of dosage changes. Don't stop suddenly; talk with your provider first. If you're in crisis or thinking about harming yourself, call or text 988 (Suicide & Crisis Lifeline), any time, day or night. In an emergency, call 911 or go to the nearest emergency room. Sources: Prozac label, Zoloft label (DailyMed).

Why Prozac’s Long Half-Life Matters

This is the biggest practical difference between the two. A medication’s half-life is the time it takes for the amount in your blood to drop by half. Zoloft’s label puts sertraline’s average at about 26 hours. Its main breakdown product lasts longer, but the label describes it as substantially less active.

Prozac’s label describes a much slower picture. With ongoing use, fluoxetine’s half-life is 4 to 6 days, and the body turns it into norfluoxetine, an active compound with a half-life of 4 to 16 days. As a result, the label says, a dose change isn’t fully reflected in the blood for several weeks, and active medication stays in the body for weeks after the last dose.

That slow fade cuts both ways. If fluoxetine has to be stopped, for example because of a side effect or an interaction, it lingers, and the label notes that this can matter. It shows up most in three everyday situations.

Missed doses. Because levels fall so slowly, a missed dose of fluoxetine makes less of a dip. In a 1998 trial of 242 people whose depression was in remission, each person’s antidepressant was replaced with a placebo for 5 to 8 days, without patients or researchers knowing which was which. People taking fluoxetine had far fewer discontinuation symptoms than people taking sertraline or paroxetine, and fewer depressive symptoms came back during the short interruption. The authors of another 1998 trial suggested fluoxetine may suit people likely to miss doses because of travel or forgetfulness. These are older studies, and neither makes skipping doses a good idea. Both Medication Guides give the same instructions for a missed dose, and your pharmacist can walk you through them.

Stopping. Prozac’s label says fluoxetine’s gradual decline at the end of treatment may minimize the risk of discontinuation symptoms. It still describes those symptoms, such as dizziness, irritability and electric-shock-like sensations, and, like Zoloft’s label, recommends lowering the dose gradually rather than stopping abruptly whenever possible. Please don’t stop a medication on your own; some can cause withdrawal symptoms or a return of symptoms if stopped suddenly. Our post on stopping medication thoughtfully explains how that conversation usually goes.

Switching. Here the long half-life matters most. Prozac’s label says to wait at least 5 weeks after stopping fluoxetine before starting an MAOI antidepressant or thioridazine. Zoloft’s label says to wait at least 14 days after stopping sertraline before starting an MAOI. Prozac’s label also advises starting certain other medications carefully if fluoxetine was taken in the previous 5 weeks, because it’s still affecting how they’re cleared. If you’re moving from Prozac to another medication, your provider will plan the timing with that in mind.

Interactions: The CYP2D6 Question

Both medications block CYP2D6, a liver enzyme that clears many other medications, including some antidepressants, antipsychotics, heart rhythm medications and beta-blockers. When CYP2D6 is blocked, levels of those medications can rise. The labels describe the strength of that effect differently.

  • Prozac’s label calls fluoxetine a potent CYP2D6 blocker that may make someone with normal enzyme activity resemble a “poor metabolizer.” In two studies, levels of the older antidepressants imipramine and desipramine rose 2- to 10-fold with fluoxetine, and the label says that effect may last 3 weeks or longer after fluoxetine is stopped.
  • Zoloft’s label says sertraline at lower doses has a less prominent effect on CYP2D6 than some others in its class, but still has the potential for clinically important effects. Its examples include metoprolol, flecainide and atomoxetine.
  • Tamoxifen, codeine and tramadol. Because fluoxetine strongly blocks CYP2D6, it can lower the active form of tamoxifen, a breast cancer medication, according to a U.S.-led pharmacogenetics guideline, so people taking tamoxifen should tell their prescriber. The same enzyme turns codeine and tramadol into their active forms, and their labels warn that CYP2D6 blockers can change how well they work.
  • Other label points. Prozac’s label notes reports of higher phenytoin and carbamazepine levels, and of both higher and lower lithium levels. Zoloft’s label says to monitor phenytoin levels, and Zoloft’s oral solution contains alcohol and can’t be used with disulfiram.

Prozac’s label also says fluoxetine’s own levels can rise with other CYP2D6-blocking medications, which it lists among the risk factors for QT prolongation. On QT, Prozac’s label goes further than Zoloft’s: it says to consider an ECG before starting and periodically in people with QT risk factors, and to avoid other medications known to prolong QT. Zoloft’s label says to use caution in people with QT risk factors. A 2026 analysis of trial data, an international study, found that fluoxetine didn’t clearly raise QT compared with placebo, while escitalopram did modestly, and antidepressants weren’t linked to early major heart problems; sertraline wasn’t part of that analysis. Genes matter here too: people whose bodies naturally process CYP2D6 slowly have higher fluoxetine levels, which Prozac’s label also lists as a QT risk factor. Pharmacogenetic testing can show how your body processes some medications; it doesn’t choose a medication for you. Bring your full medication list, including over-the-counter medicines and supplements, and ask your pharmacist to check it against either one.

Side Effects: Where the Labels Differ

Most side effects overlap, and our post on common SSRI side effects covers the shared list. Nausea and diarrhea, for example, are on both labels’ lists of most common side effects. A few differences stand out:

  • Restlessness and sleep. You may hear Prozac described as more “activating.” Prozac’s label has its own warning section on anxiety and insomnia: in its depression trials, 12% to 16% of people taking fluoxetine reported anxiety, nervousness or insomnia, compared with 7% to 9% taking placebo. Zoloft’s label lists insomnia among the most common side effects in its OCD and social anxiety trials, and sleepiness in its depression trials. The two labels draw on different trials, so they can’t settle which medication is more activating.
  • Appetite and weight. Prozac’s label notes decreased appetite, and some weight loss, in its trials. Over 6 months, a 2024 study of 183,118 U.S. patients found weight change with fluoxetine similar to sertraline. It was observational, and adherence was low.
  • Blood sugar. Prozac’s label says fluoxetine may affect blood sugar control in people with diabetes, with low blood sugar reported during treatment and high blood sugar after stopping. Zoloft’s label has no matching warning. If you have diabetes, make sure your provider knows.
  • Rash. Prozac’s label has a warning about rash and allergic reactions, which in rare cases have been serious. Zoloft’s label asks patients to report allergic reactions such as rash or hives.

Both labels warn about sexual side effects and tell prescribers to ask about them directly. Prozac’s label also says symptoms of sexual dysfunction “occasionally persist” after fluoxetine is stopped. Zoloft’s current label doesn’t include that sentence, but the labels don’t compare the two, so this alone doesn’t show that one carries more risk. Sexual side effects that last after stopping have been reported across SSRIs, not just with Prozac. Our post on sexual side effects of antidepressants covers what’s known about symptoms that last.

Which Works Better?

Researchers have compared these two many times. The results lean slightly one way without settling the question.

Reviews leaning toward sertraline. A Cochrane review of fluoxetine pooled 6 trials with 1,188 people and found fluoxetine somewhat less effective than sertraline for response; the review’s summary doesn’t report a significant difference between the two in average symptom scores at the end. Its authors said the clinical meaning of the differences they found is uncertain, and that most included studies were poorly reported and sponsored by drug companies, though they described sertraline’s advantage as possibly meaningful. An earlier Cochrane review of sertraline, based on 59 mostly low-quality studies, also found evidence favoring sertraline over fluoxetine for response in the first 6 to 12 weeks, but not for remission or later outcomes.

The largest analysis. An international team, Cipriani and colleagues in 2018, pooled 522 trials of 21 antidepressants in adults, and all of them beat placebo. In head-to-head trials, fluoxetine was among the least effective. It was also one of only two antidepressants with fewer dropouts than placebo, and both fluoxetine and sertraline were among the better tolerated. Overall, the authors found the differences between drugs mostly modest, and they named sertraline among the antidepressants with a relatively higher response and fewer dropouts. Most of the trials were funded by drug companies, and the authors rated the certainty of their evidence as moderate to very low.

A U.S. review finding no meaningful difference. A review funded by the U.S. Agency for Healthcare Research and Quality, covering 234 studies, found no clinically relevant differences in effectiveness among newer antidepressants. It concluded that the evidence doesn’t justify choosing one on effectiveness alone, while noting that they differ in how quickly they start working and in side effects.

How much these rankings can tell any one person is debated, and a 2019 reanalysis argued that the evidence behind them is weaker than it looks. If sertraline has an edge in effectiveness, it looks small, and tolerability, interactions and your own history often matter more.

Myth or fact? Prozac vs. Zoloft

Choose an answer for each to see the explanation. Nothing is saved.

  1. 1Research has proven that Zoloft works better than Prozac.

  2. 2Because Prozac lasts so long, it's fine to stop it without talking to your provider.

  3. 3PTSD and social anxiety disorder are FDA-approved uses for Zoloft but not for Prozac.

Pregnancy and Breastfeeding

Both labels say published studies haven’t shown a clear increase in the overall risk of major birth defects. Both describe possible problems in newborns exposed to SSRIs late in pregnancy and a somewhat higher risk of heavy bleeding after delivery. Both also note that people who stop antidepressants during pregnancy are more likely to have depression return. Zoloft’s oral solution contains alcohol, and its label doesn’t recommend it during pregnancy.

For breastfeeding, the labels differ. Zoloft’s reports low levels of sertraline in breast milk, and in a pooled analysis of 53 mothers and babies, no adverse reactions were seen in the infants. Prozac’s reports agitation, irritability, poor feeding and poor weight gain in some breastfed infants and advises watching for them. Our posts on medication and pregnancy and treating depression while breastfeeding go further. If you’d like us to, and with your permission, we can share information with your ob-gyn (or primary care provider) so your care fits together.

How Long Does Prozac Take to Work?

Expect a timeline much like other antidepressants. NIMH says antidepressants usually take 4 to 8 weeks to work, and that sleep, appetite, energy and concentration often improve before mood does. MedlinePlus says it may take 4 to 5 weeks or longer to feel the full benefit of fluoxetine, and a few weeks or longer for sertraline.

For OCD, the wait is often longer: NIMH notes that improvement can take 8 to 12 weeks to begin. With Prozac, a dose change also takes several weeks to show fully in the blood, which your provider factors in when judging how it’s working.

How the Choice Usually Gets Made

With no clear overall winner, the decision tends to rest on you rather than on a ranking:

  • What’s being treated, and which label covers it.
  • How easy it is for you to take medication every day. Fluoxetine’s slow fade may be more forgiving of an occasional missed dose, though that evidence comes from older trials.
  • Plans to switch or stop later. Fluoxetine’s long half-life stretches out a switch, especially to an MAOI.
  • Everything else you take, because of the CYP2D6 interactions above.
  • Age, liver health and diabetes. Prozac’s label suggests a lower or less frequent dose for older adults and people with liver problems. Zoloft’s label recommends a lower dose with mild liver problems and doesn’t recommend it with more serious liver disease.
  • Sleep and restlessness, if insomnia or anxiety is already a problem for you.
  • Pregnancy or breastfeeding plans, for the reasons above.

Needing a second try is common, and why finding the right medication can take time explains what usually comes next. For adults across New Jersey, this is the conversation our board-certified psychiatric nurse practitioners have with patients before a first prescription. If you’re comparing other SSRIs too, Lexapro vs. Zoloft sets those two side by side. Lexapro vs. Prozac compares the remaining pair. For a medication from a different family, see Wellbutrin vs. Zoloft.

For your visit

What to bring up when choosing between them

Tick what you want to cover with your provider, then copy your list. Nothing is saved or sent.

Frequently Asked Questions

Is Prozac or Zoloft better for anxiety?

It depends on the kind of anxiety. Both are FDA-approved for panic disorder in adults, and Zoloft is also approved for social anxiety disorder and PTSD. Neither label lists generalized anxiety disorder. Your provider will weigh your symptoms, history and other medications.

Is Prozac stronger than Zoloft?

Not in a way that matters for choosing. The two come in different dose ranges, so the numbers on the bottle don’t compare. Some reviews found sertraline slightly more effective, but the differences were small and their meaning uncertain.

Does Prozac stay in your system longer than Zoloft?

Yes. According to Prozac’s label, fluoxetine and its active breakdown product, norfluoxetine, stay in the body for weeks after the last dose, while sertraline’s half-life is about 26 hours. That’s why the label calls for waiting at least 5 weeks after stopping Prozac before starting an MAOI.

Can I switch from Prozac to Zoloft?

People do switch between SSRIs, and your provider can plan it with you. Because fluoxetine lingers for weeks, the plan takes into account that it will still be in your body for a while. Please don’t stop a medication on your own; some can cause withdrawal symptoms or a return of symptoms if stopped suddenly.

Can you take Prozac and Zoloft together?

They aren’t usually combined. Zoloft’s label lists other SSRIs among the medications that raise the risk of serotonin syndrome when taken together, and Prozac’s label warns about combining it with other serotonin-affecting medications.

If you’d like to talk through which one makes sense for you, a psychiatric evaluation is a good place to begin, and medication management gives you regular follow-ups to adjust the plan as you go.

This article is for general educational purposes only. It does not constitute medical advice, does not establish a provider-patient relationship, and is not a substitute for individual evaluation, diagnosis, or treatment by a qualified clinician. If you’re in crisis or thinking about harming yourself, call or text 988 (Suicide & Crisis Lifeline), any time, day or night. In an emergency, call 911 or go to the nearest emergency room.

The science: how we checked this

Sources

How we checked this

  • DailyMed (FDA labels; Prozac label version effective January 2026, DailyMed version 59 posted Jan 14, 2026; Zoloft revised 8/2023; both checked Nov 8, 2026): first U.S. approval years, approved uses in adults (including the olanzapine combinations), shared warnings, contraindications (MAOIs, pimozide, thioridazine, disulfiram with Zoloft oral solution), half-lives and the active breakdown product, the long half-life warning, discontinuation symptoms and gradual stopping, MAOI and thioridazine waiting periods, the 5-week caution for other medications, CYP2D6 and other interactions, the anxiety and insomnia warning and trial figures, most common side effects, appetite and weight, blood sugar, rash, sexual side effects (including "occasionally persist"), pregnancy, breastfeeding, missed-dose instructions in each Medication Guide, and dose adjustments for older adults and liver problems (described without numbers).
  • FDA: off-label prescribing. NIMH: how long antidepressants take to work, and the timing for OCD. MedlinePlus: time to full benefit for each medication.
  • Rosenbaum 1998 (U.S.) and Zajecka 1998 (U.S.): fluoxetine and treatment interruption or abrupt stopping.
  • Magni 2013 (Cochrane) and Cipriani 2010 (Cochrane): reviews leaning toward sertraline over fluoxetine. Cipriani 2018 (international): the large network analysis, its head-to-head and dropout findings, and its certainty rating. Gartlehner 2011 (funded by the U.S. Agency for Healthcare Research and Quality): no clinically relevant differences. Munkholm 2019: the critique of the evidence. Petimar 2024 (U.S.): weight at 6 months.
  • Added Nov 8, 2026 (OpenEvidence fixes): Prozac label (effective January 8, 2026): ECG and QT-prolonging drugs, CYP2D6 poor metabolizers, seizures, blood sugar, thinking and motor skills, long half-life, pediatric uses, and "occasionally persist." Zoloft label: false-positive benzodiazepine screens, QT caution, seizures, pediatric OCD. Ostinelli 2026 (international): QT. CPIC 2018 (U.S.-led) and the codeine and tramadol labels: CYP2D6. Bala 2018 (U.S.): persistent sexual symptoms across SSRIs. Cipriani 2010 full text: response vs. remission and later outcomes. Cipriani 2018 full text: mostly modest differences, sertraline named, 78% of trials funded by drug companies. Rosenbaum 1998: discontinuation symptoms and reemergence of depressive symptoms.
  • The checklist comes from this article's own advice.
  • Written in our own words; the quick answer, key takeaways and key points restate this article.
Alyssa Killion

Clinically reviewed by

Alyssa Killion, MSN, APN, PMHNP-BC

Board-certified psychiatric mental health nurse practitioner and founder of ANK Behavioral Health, providing telehealth psychiatric care to adults across New Jersey.

Written by ANK Behavioral Health. Reviewed on November 8, 2026.